These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2471012)

  • 1. Serum lipids, lipoproteins, hemodynamics, and hemostasis in doxazosin-treated monkeys.
    Karge WH; Kowala MC; Weiner EJ; Nicolosi RJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S25-9; discussion S29-30. PubMed ID: 2471012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prazosin on hemodynamics, hemostasis, and serum lipid and lipoprotein levels in normal and hypercholesterolemic monkeys.
    Karge WH; Weiner EJ; Kowala MC; Graham RM; Nicolosi RJ
    Am J Med; 1989 Jan; 86(1B):19-23. PubMed ID: 2913768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys.
    Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ
    Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of doxazosin on platelet aggregation, platelet adhesion and blood coagulation in cynomolgus monkeys.
    Weiner EJ; Stucchi AF; Foxall TL; Shwaery GT; Yoganathan S; Nicolosi RJ
    Atherosclerosis; 1994 May; 107(1):35-44. PubMed ID: 7945557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
    Pool JL; Taylor AA; Nelson EB
    Am J Med; 1989 Aug; 87(2A):57S-61S. PubMed ID: 2569825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatic cholesterol synthesis by the alpha 1-adrenoceptor blocker doxazosin in the hypercholesterolemic golden hamster.
    Jansen H; Lammers R; Baggen MG; Penders JM; Birkenhäger JC
    Life Sci; 1989; 44(15):1013-7. PubMed ID: 2564614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of doxazosin on plasma lipids and atherogenesis: a preliminary report.
    Kowala MC; Nicolosi RJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S45-9; discussion S49. PubMed ID: 2471015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model.
    Foxall TL; Shwaery GT; Stucchi AF; Nicolosi RJ; Wong SS
    Am J Pathol; 1992 Jun; 140(6):1357-63. PubMed ID: 1351367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters.
    Kowala MC; Nunnari JJ; Durham SK; Nicolosi RJ
    Atherosclerosis; 1991 Nov; 91(1-2):35-49. PubMed ID: 1687433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of doxazosin on lipid transport in rats and hamsters.
    Ontko JA; Woodside WF
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S31-6; discussions 36-7. PubMed ID: 2471013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T; Westlie L; Daae LN
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A; Daae LN; Kierulf P; Brusletto B; Holme I; Syvertsen JO
    J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of serum lipids in hypercholesterolaemic rabbits treated with doxazosin.
    Leren TP; Berg K
    Scand J Clin Lab Invest; 1988 Jun; 48(4):313-7. PubMed ID: 2907180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
    Swindell AC; Valentine JJ
    Am J Cardiol; 1987 May; 59(14):29G-34G. PubMed ID: 2884850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of doxazosin and other antihypertensives on serum lipid levels and lipoprotein lipase in the C57BR/cdJ mouse.
    Krupp MN; Hoover KW; Valentine JJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S11-8; discussion S18-9. PubMed ID: 2471010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
    Pool JL
    Am J Cardiol; 1987 May; 59(14):46G-50G. PubMed ID: 2884853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats.
    Mackintosh VS; Elsegood CL; Redgrave TG
    Clin Exp Pharmacol Physiol; 1991 Nov; 18(11):775-88. PubMed ID: 1685947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS; Hirokawa WT
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
    Jansen H; Lammers R; Baggen MG; Birkenhäger JC
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S5-9; discussion S9-10. PubMed ID: 2471016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.